Delcath Systems, Inc.
NASDAQ:DCTHMedical - Devices
Healthcare
$19.24 -1.91%
-$0.23 today
- Market cap
- $669.32M
- Beta
- 0.52
- P/E (TTM)
- 751.4
- EPS (TTM)
- $0.02
52W Low $8.12High $14.48
Volume 0.46M
Average 0.42M
Income Statement
Follow revenue through to earnings.
Revenue
$85.23M
FY 2025 · Annual
+129.1% YoYOperating Income
$660,000.00
FY 2025 · Annual
Net Income
$2.70M
FY 2025 · Annual
Income Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.56M | 2.72M | 2.07M | 37.21M | 85.23M |
| Cost of Revenue | 671K | 686K | 635K | 6.19M | 11.8M |
| Gross Profit | 2.88M | 2.03M | 1.43M | 31.02M | 73.43M |
| Gross Margin | 81.1% | 74.8% | 69.2% | 83.4% | 86.2% |
| Research & Development | 13.78M | 18.58M | 17.5M | 13.87M | 29.25M |
| Selling, General & Admin | 13.64M | 17.3M | 22.11M | 29.55M | 43.53M |
| Operating Expenses | 27.42M | 35.89M | 39.61M | 43.43M | 72.77M |
| Depreciation & Amortization | 146K | 132K | 399K | 229K | 349K |
| EBITDA | (24.32M) | (33.69M) | (45.84M) | (26.16M) | 3.86M |
| EBITDA Margin | -684.0% | -1239.1% | -2219.9% | -70.3% | 4.5% |
| Operating Income | (24.53M) | (33.85M) | (38.18M) | (12.41M) | 660K |
| Operating Margin | -690.0% | -1245.1% | -1849.0% | -33.4% | 0.8% |
| Interest Income | 0 | 0 | 0 | 125K | 2.92M |
| Interest Expense | 1.19M | 2.69M | 1.44M | 0 | 0 |
| Other Income / Expenses | (1.12M) | (2.66M) | (9.5M) | (13.98M) | 2.85M |
| Income Before Tax | (25.65M) | (36.51M) | (47.68M) | (26.39M) | 3.51M |
| Pre-Tax Margin | -721.5% | -1342.7% | -2308.9% | -70.9% | 4.1% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 810K |
| Net Income | (25.65M) | (36.51M) | (47.68M) | (26.39M) | 2.7M |
| Net Margin | -721.5% | -1342.7% | -2308.9% | -70.9% | 3.2% |
| EPS (Basic) | (3.59) | (4.12) | (2.94) | (0.93) | 0.08 |
| EPS (Diluted) | (3.59) | (4.12) | (2.94) | (0.93) | 0.07 |
| 7.15M | 8.86M | 16.23M | 28.51M | 35.82M | |
| 7.15M | 8.86M | 16.23M | 28.51M | 39.92M |
DCTH Earnings Waterfall · TTM
NASDAQ:DCTH · Revenue to Net Income
Key Ratios
EPS$0.01
Gross Margin86.0%
Net Margin0.4%
P/E Ratio9.1
P/S Ratio17.6
Analysis
$90.4M of revenue converted into $561.0K of net income for the selected period. Gross margin is 86.0% and net margin is 0.4%, showing how much revenue survives after costs and taxes. EPS is $0.01, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 12, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| SC 13G | SC 13G filing | Oct 27, 2026 |
How much revenue does DCTH generate?
Delcath Systems, Inc. (DCTH) reported $85.23M of revenue in fiscal 2025.
Is DCTH profitable?
Delcath Systems, Inc. (DCTH) reported $2.70M of net income, with a net margin of 3.2%.
Continue the stock analysis
Jump to another research area for this company.